FDA Banned The Monoclonal Antibody Treatment!

The FDA banned the use of two monoclonal antibody treatments. The Biden Admin would ban the distribution of monoclonal antibody treatments made by Regeneron Pharmaceuticals and Eli Lilly because of the ineffectiveness against Omicron.

“We want to make sure that patients get treatments that are effective, not treatments that don’t work,” said one of the officials, who spoke on the condition of anonymity to describe internal discussions. The Washington Post reported.

Join The True Defender Telegram Chanel Here:

‘’The FDA action will involve revising the emergency use authorizations for the monoclonal antibodies. The agency will not revoke the authorizations in case the treatments become useful against a future coronavirus variant.’’ The report continued.

Biden’s Admin officials emphasized that several therapies are effective against Omicron as sotrovimab and the antiviral pills by Pfizer.

The use of ramdesivir is an outpatient therapy that got the green light from the regulators.

Watch the video below:

Banned Video

Addison Wilson

A passionate teacher in English Language and Literature ready to give her best! Developing and implementing diverse curriculums covering a wide range of subjects. With my problem-solving skills, every job will be easily completed, so punctuation is my strength. Highly skilled at motivating students through positive encouragement and reinforcement of concepts via interactive classroom instruction and observation. My working style fits every personality type, so it makes me a great team player. I have completed numerous journalistic projects successfully, so digging for further information is my field. Fighter for freedom of speech! The truth must be revealed!

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Back to top button

Adblock Detected

For continue reading on the site please disable the Ad-block